State of the Society. Intravenous Nurses Society.
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The Intravenous Nurses Society (INS) recognizes the use of unlicensed assistive personnel in nursing. The Society believes unlicensed assistive personnel may assist the registered nurse in preparing equipment and recording statistics; however, to ensure that safe, quality nursing care is provided to all patients receiving infusion therapies, the Intravenous Nurses Society strongly recommends that unlicensed assistive personnel not be used in the role of delivering intravenous therapy.
Oncology nursing is one of the fastest moving and most exciting specialties in nursing today. ONS, not surprisingly, is one of the strongest specialty groups. Taylor profiles the history of this group.
The Intravenous Nurses Society contends that intravenous nurse specialists should be involved wherever infusion therapies are delivered. Although the evolving health care environment has led to an increased number of practice settings, the need for quality patient care is still paramount. Intravenous nurse specialists have the skill and expertise to ensure competent practice, as well as the ability to keep costs down.
The Intravenous Nurses Society recognizes the importance of engineering and work practice controls to minimize or eliminate occupational exposure to bloodborne pathogens. However, such controls must be carefully balanced to maximize patient care and minimize personnel risk. Decisions regarding the development, selection, and use of such products must take into consideration: patient safety, desired therapeutic outcomes, ethical considerations, effective use of resources and cost, and practitioner protection.
The Intravenous Nurses Society recognizes the inherent risks to the patient and the caregiver associated with the administration of antineoplastic agents. Individuals involved in the administration of these agents should have specialty education and validation of competency on a continuum and be licensed as a physician or a registered nurse.
The Intravenous Nurses Society (INS) contends that registered intravenous nurses should be involved in the purchasing decisions of vascular access devices. Because nurses are the end-users of these products, they have knowledge on the quality and reliability of intravenous therapy products. Although cost containment concerns are paramount, cost should not be the only criteria observed in making purchasing decisions.
The Intravenous Nurses Society (INS) contends that registered intravenous nurses as the ultimate end-users of vascular access devices are the most qualified individuals for the selection of these products. Although the physician is responsible for initiating orders, nurses are the most appropriate health care providers for determining the correct vascular access product to be used to deliver the ordered therapies.
The Intravenous Nurses Society (INS) believes that the intravenous trained licensed practical nurse and the licensed vocational nurse can aid in the delivery of some aspects of intravenous therapy under the supervision of the registered nurse; however, the registered nurse shall be the primary practitioner in this specialty.
Since 1989, the Nursing School attached to the Free University, Brussels, has organized post-basic courses in cancer nursing, with the collaboration of the Belgian Oncology Nursing Society (French speaking) (SIO) and a comprehensive cancer centre, the Jules Bordet Institute. The 1-day-a-week course evolves over 30 weeks and is open to registered nurses. Its structure and its content respect the recommendations of the Core Curriculum for a Post-Basic Course in Cancer Nursing (EONS, 1989). However, there are some differences related to the entry requirements, the clinical experience, and the evaluation of both the course and the students' performance. So far, 72 nurses from different cancer units from the southern part of Belgium have obtained the certificate at the end of this course. In parallel with the 1-day-a-week course, seven modular courses were set up during the first semester of 1992, with the financial support of the 'Europe against Cancer' Programme. Each module tackles a specific theme: Basic Principles in Oncology Nursing; Training the Trainers; Prevention and Early Screening; Rehabilitation--Palliative Care--Psycho-oncology (one short and one long module); Radiotherapy; and Chemotherapy.
The Intravenous Nurses Society (INS) recognizes the need for uniform terminology for peripherally inserted central catheters (PICCs) to encourage standardization for indications, care, and maintenance strategies for these devices. It also recognizes the need for recommendations regarding the choice, use, management, and discontinuation of PICCs to promote positive patient outcomes and enhance patient comfort, safety, and satisfaction.
The Intravenous Nurses Society (INS) recognizes the need for uniform terminology for midline and midclavicular catheters to encourage standardization for indications, care, and maintenance strategies for these devices. It also recognizes the need for recommendations regarding the choice, use, management, and discontinuation of midline and midclavicular catheters to promote positive patient outcomes and enhance patient comfort, safety, and satisfaction.
Explore the source record for details and available documents.